Location
United States, North America
Check Size
$1M - $75M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
About Investor
Stephen Squinto is an Executive Partner at Orbimed based in New York. He focuses on investing in Pharmaceuticals and BioTech at Seed and Series A stages. His typical investment range is $1M to $75.0M. Squinto has a verified background in venture capital with Orbimed, where he serves as an executive partner.
Previous investments
Enlaza Therapeutics
100M |2024
iECURE
50M |2021
Gennao Bio
40M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP